Evidence map›Paper›PMID 39246002›Full record

ArticleUnited European gastroenterology journal2025

Fecal urgency and incontinence in inflammatory bowel disease perceived by physician and patient: Results from the Swiss fecal urgency survey.

Nadia Wespi, Stephan Vavricka, Stephan Brand, Patrick Aepli, Emanuel Burri, Benjamin Misselwitz, Frank Seibold, Petr Hruz, Laurent Peyrin-Biroulet, Alain Schoepfer and 4 more

Abstract read
In one paragraph

Article in United European gastroenterology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nadia WespiDepartment of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Stephan VavrickaDepartment of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Stephan BrandDivision of Gastroenterology and Hepatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Patrick AepliDivision of Gastroenterology and Hepatology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
Emanuel BurriDivision of Gastroenterology and Hepatology, University Medical Clinic, Cantonal Hospital Baselland, Liestal, Switzerland.
Benjamin MisselwitzDepartment of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.
Frank SeiboldIntesto Crohn and Colitis Center, Bern, Switzerland.
Petr HruzDivision of Gastroenterology and Hepatology, Clarunis, University Hospital Basel, Basel, Switzerland.
Laurent Peyrin-BirouletDepartment of Gastroenterology, INFINY Institute, FHU-CURE, INSERM NGERE, Nancy University Hospital, Vandœuvre-lès-Nancy, France.ORCID 0000-0003-2536-6618
Alain SchoepferDivision of Gastroenterology and Hepatology, CHUV University Hospital Lausanne and University of Lausanne UNIL, Lausanne, Switzerland.
Luc BiedermannDepartment of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Christiane SokollikPediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital, Bern University Hospital, University of Bern, Bern, Switzerland.
Gerhard RoglerDepartment of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Thomas GreuterDepartment of Gastroenterology and Hepatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.ORCID 0000-0003-2065-3925

Funding

Novartis Foundation for Medical-Biological ResearchSwiss National Science Foundation P2ZHP3_168561Swiss Society of Gastroenterology
6 · The paper itself

Abstract

introductionAlthough increasingly appreciated, little is known about the prevalence of fecal urgency, fecal incontinence and differences between patients' and physicians' perception in inflammatory bowel disease (IBD).

methodsWe performed an online patient and physician survey to evaluate the assessment, prevalence and impact of fecal urgency and incontinence in IBD.

resultsA total of 593 patients (44.0% ulcerative colitis (UC), 53.5% Crohn's disease (CD), 2.2% indeterminate colitis, 2 not specified) completed the survey (65.8% females, mean age 47.1 years). Fecal urgency was often reported (UC: 98.5%, CD: 96.2%) and was prevalent even during remission (UC: 65.9%, CD: 68.5%). Fecal urgency considerably impacted daily activities (visual analog scale [VAS] 5, IQR 3-8). Yet, 22.8% of patients have never discussed fecal urgency with their physicians. Fecal incontinence was experienced by 44.7% of patients and 7.9% on a weekly basis. Diapers/pads were required at least once a month in 20.4% of patients. However, 29.7% of patients never talked with their physician about fecal incontinence. UC was an independent predictor for the presence of moderate-severe fecal urgency (OR 1.65, 95% CI 1.13-2.41) and fecal incontinence (OR 1.77, 95% CI 1.22-2.59). All physicians claimed to regularly inquire about fecal urgency and incontinence. However, the impact of these symptoms on daily activities was overestimated compared with the patient feedback (median VAS 8 vs. 5, p = 0.0113, and 9 vs. 5, p = 0.0187).

conclusionsFecal urgency and incontinence are burdensome symptoms in IBD, with a similar prevalence in UC and CD. A mismatch was found between the physician and patient perception. These symptoms should be addressed during outpatient visits.

Indexed as

Colitis, UlcerativeCrohn DiseaseFecal IncontinenceInflammatory Bowel DiseasesAdultAgedFemaleHumansMaleMiddle AgedPhysician-Patient RelationsPhysiciansPrevalenceQuality of LifeSeverity of Illness IndexSurveys and QuestionnairesCrohn's diseasefecal incontinencefecal urgencyinflammatory bowel diseaseulcerative colitis

Identifiers

PMID39246002
PMCPMC11999039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.